NO982715D0 - Endotel celle-proliferasjonsinhibitor og fremgangsmÕte for anvendelse - Google Patents

Endotel celle-proliferasjonsinhibitor og fremgangsmÕte for anvendelse

Info

Publication number
NO982715D0
NO982715D0 NO982715A NO982715A NO982715D0 NO 982715 D0 NO982715 D0 NO 982715D0 NO 982715 A NO982715 A NO 982715A NO 982715 A NO982715 A NO 982715A NO 982715 D0 NO982715 D0 NO 982715D0
Authority
NO
Norway
Prior art keywords
cell proliferation
endothelial cell
proliferation inhibitor
inhibitor
endothelial
Prior art date
Application number
NO982715A
Other languages
English (en)
Other versions
NO982715L (no
NO321775B1 (no
Inventor
Yihai Cao
Moses Folkman
Michael S O'reilly
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/763,528 external-priority patent/US5854221A/en
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of NO982715D0 publication Critical patent/NO982715D0/no
Publication of NO982715L publication Critical patent/NO982715L/no
Publication of NO321775B1 publication Critical patent/NO321775B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Farming Of Fish And Shellfish (AREA)
NO19982715A 1995-12-13 1998-06-12 Fremgangsmate for a hemme endotelcelleproliferasjon in vitro, farmasoytisk blanding som omfatter en endotelcelleproliferasjons-inhibitor, samt anvendelse. NO321775B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US851995P 1995-12-13 1995-12-13
US08/763,528 US5854221A (en) 1996-12-12 1996-12-12 Endothelial cell proliferation inhibitor and method of use
PCT/US1996/020447 WO1997023500A1 (en) 1995-12-13 1996-12-13 Endothelial cell proliferation inhibitor and method of use

Publications (3)

Publication Number Publication Date
NO982715D0 true NO982715D0 (no) 1998-06-12
NO982715L NO982715L (no) 1998-08-12
NO321775B1 NO321775B1 (no) 2006-07-03

Family

ID=26678280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982715A NO321775B1 (no) 1995-12-13 1998-06-12 Fremgangsmate for a hemme endotelcelleproliferasjon in vitro, farmasoytisk blanding som omfatter en endotelcelleproliferasjons-inhibitor, samt anvendelse.

Country Status (20)

Country Link
US (1) US20010016644A1 (no)
EP (1) EP0869970B1 (no)
JP (1) JP3684371B2 (no)
KR (1) KR100477280B1 (no)
CN (1) CN1554444A (no)
AT (1) ATE262537T1 (no)
AU (1) AU710612B2 (no)
BR (1) BR9612115A (no)
CA (1) CA2240296C (no)
CZ (1) CZ298612B6 (no)
DE (1) DE69631972T2 (no)
DK (1) DK0869970T3 (no)
ES (1) ES2217340T3 (no)
HK (1) HK1017692A1 (no)
HU (1) HUP9900979A3 (no)
NO (1) NO321775B1 (no)
NZ (1) NZ330537A (no)
PL (1) PL188719B1 (no)
PT (1) PT869970E (no)
WO (1) WO1997023500A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE262537T1 (de) * 1995-12-13 2004-04-15 Childrens Medical Center Proliferationsinhibitor von endothellzellen und dessen verwendung
US5801146A (en) * 1996-05-03 1998-09-01 Abbott Laboratories Compound and method for inhibiting angiogenesis
IL126626A0 (en) * 1996-05-03 1999-08-17 Abbott Lab Novel antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
US6699838B1 (en) 1996-05-03 2004-03-02 Abbott Laboratories Antiangiogenic peptides
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
WO1999000420A1 (en) * 1997-06-26 1999-01-07 Karolinska Innovations Ab Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
WO1999026480A1 (en) * 1997-11-20 1999-06-03 Genetix Pharmaceuticals, Inc. Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
US6632961B1 (en) 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
AU764103B2 (en) * 1999-05-17 2003-08-07 Conjuchem Biotechnologies Inc. Long lasting anti-angiogenic peptides
EP1180121B9 (en) 1999-05-17 2004-09-08 Conjuchem, Inc. Long lasting insulinotropic peptides
US7144854B1 (en) 1999-09-10 2006-12-05 Conjuchem, Inc. Long lasting anti-angiogenic peptides
EP1242451A2 (en) * 1999-12-15 2002-09-25 EntreMed, Inc. Compositions and methods for inhibiting endothelial cell proliferation
CA2421251A1 (en) 2000-09-05 2002-03-14 Karolinska Innovations Ab Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
US20030054988A1 (en) * 2000-11-02 2003-03-20 Weidong-Richard Ji Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
EP1714151A4 (en) * 2004-01-21 2009-06-10 Fujirebio America Inc DETECTION OF PEPTIDES RELATED TO MESOTHELIN / MEGAKARYOCYTIC POTENTIAL FACTOR IN PERITONEAL LIQUID FOR THE ASSESSMENT OF THE PERITONEUM AND PERITONEAL CAVE
CN100355458C (zh) * 2005-03-16 2007-12-19 北京大学 人增殖抑制基因－腺病毒表达载体的应用
WO2010138631A1 (en) 2009-05-26 2010-12-02 Biolex Therapeutics, Inc. Compositions and methods for production of aglycosylated plasminogen
CN103060265B (zh) * 2013-01-23 2014-12-03 山东大学 老年大鼠脑血管内皮细胞原代培养方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
HUT64977A (en) * 1992-07-30 1994-03-28 Yeda Res & Dev Synthetical peptone derivatives of vitronectine and pharmaceutical preparaties containing them
AU2355895A (en) * 1994-04-26 1995-11-16 Pharmacia & Upjohn Company Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
CN1309833C (zh) * 1994-04-26 2007-04-11 儿童医学中心公司 血管生成抑制素及其在制备药物中的用途
EP0824546B1 (en) * 1995-04-26 2007-07-25 The Children's Medical Center Corporation Angiostatin fragments and methods of use
ATE262537T1 (de) * 1995-12-13 2004-04-15 Childrens Medical Center Proliferationsinhibitor von endothellzellen und dessen verwendung

Also Published As

Publication number Publication date
HUP9900979A3 (en) 2001-10-29
HK1017692A1 (en) 1999-11-26
AU710612B2 (en) 1999-09-23
EP0869970B1 (en) 2004-03-24
KR19990072126A (ko) 1999-09-27
WO1997023500A1 (en) 1997-07-03
JP2002502359A (ja) 2002-01-22
CA2240296A1 (en) 1997-07-03
ATE262537T1 (de) 2004-04-15
CN1554444A (zh) 2004-12-15
KR100477280B1 (ko) 2005-07-18
JP3684371B2 (ja) 2005-08-17
EP0869970A1 (en) 1998-10-14
HUP9900979A2 (hu) 1999-07-28
US20010016644A1 (en) 2001-08-23
DE69631972T2 (de) 2005-01-05
PL327200A1 (en) 1998-11-23
CZ298612B6 (cs) 2007-11-21
NZ330537A (en) 2001-06-29
CA2240296C (en) 2004-05-04
PL188719B1 (pl) 2005-04-29
NO982715L (no) 1998-08-12
DE69631972D1 (de) 2004-04-29
PT869970E (pt) 2004-08-31
DK0869970T3 (da) 2004-07-05
ES2217340T3 (es) 2004-11-01
EP0869970A4 (en) 2002-01-30
NO321775B1 (no) 2006-07-03
AU1687097A (en) 1997-07-17
BR9612115A (pt) 1999-02-17
CZ182898A3 (cs) 1998-10-14

Similar Documents

Publication Publication Date Title
NO982715D0 (no) Endotel celle-proliferasjonsinhibitor og fremgangsmÕte for anvendelse
ATE281469T1 (de) Inhibitor des wachstumsfaktors für gefäss- endothelzellen
ATE172743T1 (de) Nachweis von kollagenabbau -i(in vivo)
DE69433168D1 (de) In vitro vermehrung von stammzellen
FI962350A (fi) BPM-12, BMP-13 sekä niiden jännettä indusoivat koostumukset
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
ATE183196T1 (de) Peptidinhibitoren von fibronectin und verwandten kollagen-bindenden proteinen
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
DE69835215D1 (de) Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen
EP0830130A4 (en) TNF-ALPHA CONVERTING ENZYME
EP0675728A4 (en) MEANS AND METHODS FOR IMPROVING KERATINOYCTE ADHESION TO THE SKIN.
ATE170631T1 (de) Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
SE9600742D0 (sv) Vridbart arrangemang
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
DE69635457D1 (de) Deprenyl induziertes protein
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
MY106261A (en) Anti-inflammatory 1-heteroaryl oxindole-3-carboxamides.
RU95114125A (ru) Ингибитор пролиферации стволовых кроветворных клеток

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees